该产品的获批，进一步丰富了集团的产品组合，尤其是高端手术及诊断类产品。集团将持续的为客户和患者带来更多更好的产品及解决方案。On March 13, Gelonghui reported that GAUSH MEDITECH (02407.HK) announced that a recently important upstream partner, Heidelberg Company from Germany, represented by its wholly-owned subsidiary in Peking, GAUSH YUANWANG Technology Co., Ltd., has obtained the medical instruments registration certificate approved by the National Medical Products Administration of China for an ANTERION ophthalmic diagnostic device (a three-in-one anterior segment multi-modal imaging diagnostic platform).
The ANTERION ophthalmic diagnostic device is a multi-modal imaging diagnostic platform that integrates biometric measurement, corneal topography, and anterior segment OCT, which can play an important role in multiple sub-specialties in ophthalmology such as refraction, corneal disease, glaucoma, and vision care. For instance, in refractive surgery, the HEIDERBERG's ANTERION ophthalmic diagnostic device can accurately assess corneal epithelial thickness (ETM) and visual quality, guiding personalized cutting plans; and in cataract surgery, by combining corneal topography and biometric data, it can reduce the risk of postoperative refractive surprises.
The ANTERION ophthalmic diagnostic device utilizes SS-OCT technology with a wavelength of 1300nm, featuring strong penetration, fast scanning speed, and high imaging resolution. Combined with eye-tracking and ray-tracing technologies, it offers precise, efficient, and comprehensive anterior segment diagnosis and treatment solutions. Moreover, one device can complete multiple examinations, greatly optimizing clinical workflow and enhancing the efficiency of anterior segment diagnosis and treatment.
The approval of this product further enriches the group's product portfolio, especially for high-end surgical and diagnostic products. The group will continuously bring more and better products and solutions to customers and patients.
Today, after hitting the high near 24,000 in the early session and entering bearish positions, the index fell sharply by nearly over 600 points, immediately recouping yesterday's losses significantly.
Moreover, today it broke the new high again, reaching a maximum of 24,076, but by the end of the market, it fell back by about 70 points, producing a bearish candle. The current trend has not yet been broken, but from the previous low until now, it has risen close to 6,000 points. It is believed that those with positions can continue to hold until there is a clear trend reversal for profit-taking. Those without positions can wait for a pullback to get in. Actually, it is hoped for a quick pullback, as it allows for entry and also provides a healthy breath.
Currently, the outlook remains the same as before. It is believed that even if there is a pullback, it shouldn't be too deep. However, if Futures fail to stabilize and close below 22,350, there may still be room for decline. The chance of Futures falling below 21,400 in the short term should be low, so it is considered that if a significant pullback occurs, it presents a good opportunity to incrementally go long. Recently, there has been a consistent approach to not hold positions overnight, only focusing on immediate trades, as there is no high chasing and no casual short selling.
Comment(0)
Reason For Report